(4R)-4-[(1R)-1-[[2-methyl-5-(6-propan-2-yloxy-3-pyridinyl)-1,3-benzothiazol-7-yl]oxy]ethyl]pyrrolidin-2-one
C22H25N3O3S — CID 118396496
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R)-4-[(1R)-1-[[2-methyl-5-(6-propan-2-yloxy-3-pyridinyl)-1,3-benzothiazol-7-yl]oxy]ethyl]pyrrolidin-2-one
(4R)-4-[(1R)-1-[[2-methyl-5-(6-propan-2-yloxy-3-pyridinyl)-1,3-benzothiazol-7-yl]oxy]ethyl]pyrrolidin-2-one (PubChem CID 118396496) has the molecular formula C22H25N3O3S and a molecular weight of 411.53 g/mol. Its IUPAC name is (4R)-4-[(1R)-1-[[2-methyl-5-(6-propan-2-yloxy-3-pyridinyl)-1,3-benzothiazol-7-yl]oxy]ethyl]pyrrolidin-2-one.
Molecular Properties
| Compound Name | (4R)-4-[(1R)-1-[[2-methyl-5-(6-propan-2-yloxy-3-pyridinyl)-1,3-benzothiazol-7-yl]oxy]ethyl]pyrrolidin-2-one |
|---|---|
| PubChem CID | 118396496 |
| Molecular Formula | C22H25N3O3S |
| Molecular Weight | 411.53 g/mol |
| Exact Mass | 411.16 |
| IUPAC Name | (4R)-4-[(1R)-1-[[2-methyl-5-(6-propan-2-yloxy-3-pyridinyl)-1,3-benzothiazol-7-yl]oxy]ethyl]pyrrolidin-2-one |
| SMILES | Cc1nc2cc(-c3ccc(OC(C)C)nc3)cc(O[C@H](C)[C@H]3CNC(=O)C3)c2s1 |
| InChI | InChI=1S/C22H25N3O3S/c1-12(2)27-21-6-5-15(10-24-21)16-7-18-22(29-14(4)25-18)19(8-16)28-13(3)17-9-20(26)23-11-17/h5-8,10,12-13,17H,9,11H2,1-4H3,(H,23,26)/t13-,17-/m1/s1 |
| InChIKey | BEIRZEPFGHPCEV-CXAGYDPISA-N |
| XLogP | 4.36 |
| TPSA | 73.34 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 411.53 |
| LogP ≤ 5 | 4.36 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118396496 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.